Dr. Zou Haidong (邹海东) - Director of Ophthalmology at Shanghai General Hospital

Dr. Zou Haidong (邹海东) - Director of Ophthalmology at Shanghai General Hospital

Introduction

Dr. Zou Haidong (邹海东) is the Director of the Department of Ophthalmology at Shanghai General Hospital (Shanghai First People's Hospital), affiliated with Shanghai Jiao Tong University School of Medicine, and one of China's most distinguished ophthalmologists. With over 20 years of specialized experience, Dr. Zou is nationally and internationally recognized for his expertise in retinal diseases, diabetic eye disease, age-related macular degeneration (AMD), glaucoma, and comprehensive ophthalmic care. He is a leading authority on diabetic retinopathy screening and management in China, having pioneered large-scale population-based eye disease screening programs that have transformed the early detection and prevention of blindness from diabetic eye disease across China. His commitment to clinical excellence, public health innovation, and evidence-based ophthalmology has made Shanghai General Hospital's Department of Ophthalmology one of the leading eye care centers in China, and a trusted destination for international patients seeking expert ophthalmic care in Shanghai.

Academic Distinctions & Leadership

  • Director, Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
  • Professor of Ophthalmology, Shanghai Jiao Tong University School of Medicine
  • Chief Physician, Shanghai General Hospital
  • Chairman, Ophthalmology Branch, Shanghai Medical Association
  • Vice Chairman, Ophthalmology Branch, Chinese Medical Association
  • Chairman, Diabetic Eye Disease Committee, Chinese Medical Association Ophthalmology Branch
  • Member, Asia-Pacific Academy of Ophthalmology (APAO)
  • Member, American Academy of Ophthalmology (AAO)
  • Member, European Society of Retina Specialists (EURETINA)
  • Editorial Board Member, multiple leading ophthalmology journals (Chinese and international)
  • Recipient, National Science and Technology Progress Award
  • Recipient, Shanghai Science and Technology Award (multiple times)
  • Recipient, Chinese Medical Science and Technology Award

Specializations & Expertise

Diabetic Eye Disease

  • Diabetic retinopathy (all stages) — diagnosis, monitoring, and treatment
  • Diabetic macular edema (DME) — anti-VEGF injections, laser, and combination therapy
  • Proliferative diabetic retinopathy — panretinal photocoagulation (PRP) and vitrectomy
  • Tractional retinal detachment from diabetic retinopathy — vitreoretinal surgery
  • Diabetic vitreous hemorrhage — vitrectomy
  • Neovascular glaucoma from diabetic retinopathy
  • Population-based diabetic retinopathy screening program design and implementation

Retinal Diseases

  • Age-related macular degeneration (AMD) — wet and dry — anti-VEGF therapy (ranibizumab, aflibercept, bevacizumab)
  • Retinal vein occlusion (branch and central) — anti-VEGF and laser
  • Retinal artery occlusion
  • Rhegmatogenous retinal detachment — vitrectomy and scleral buckle
  • Macular hole surgery
  • Epiretinal membrane (macular pucker) surgery
  • Myopic macular degeneration and myopic CNV
  • Central serous chorioretinopathy (CSC)
  • Inherited retinal dystrophies (diagnosis and management)
  • Uveitis with retinal involvement

Glaucoma

  • Primary open-angle glaucoma (POAG) — medical, laser, and surgical management
  • Primary angle-closure glaucoma (PACG) — laser iridotomy, iridoplasty, and surgery
  • Normal tension glaucoma
  • Secondary glaucoma (neovascular, uveitic, pseudoexfoliative)
  • Trabeculectomy and glaucoma drainage device implantation
  • Minimally invasive glaucoma surgery (MIGS)
  • Glaucoma in children (pediatric glaucoma)

Cataract Surgery

  • Phacoemulsification cataract surgery with premium IOL implantation
  • Multifocal and extended depth of focus (EDOF) IOL implantation
  • Toric IOL for astigmatism correction
  • Complex cataract surgery (dense cataracts, small pupils, pseudoexfoliation)
  • Combined cataract and glaucoma surgery
  • Combined cataract and vitreoretinal surgery
  • Posterior capsule opacification (YAG laser capsulotomy)

Refractive Surgery

  • LASIK and LASEK for myopia, hyperopia, and astigmatism
  • SMILE (small incision lenticule extraction)
  • Phakic IOL implantation (ICL) for high myopia
  • Refractive lens exchange

Oculoplastic & Orbital Surgery

  • Ptosis repair (eyelid drooping)
  • Entropion and ectropion repair
  • Lacrimal system surgery (dacryocystorhinostomy)
  • Orbital tumor surgery
  • Thyroid eye disease (Graves' orbitopathy) management and surgery

Diabetic Retinopathy Screening & Public Health

  • Design and implementation of population-based diabetic retinopathy screening programs
  • AI-assisted diabetic retinopathy screening systems
  • Telemedicine-based eye disease screening
  • Community and hospital-based screening program management
  • Health policy and guideline development for diabetic eye disease in China

Clinical Excellence & Innovation

Dr. Zou has performed thousands of ophthalmic procedures throughout his distinguished career and has evaluated and treated tens of thousands of patients with retinal diseases, glaucoma, and other eye conditions. His department at Shanghai General Hospital is one of the largest and most comprehensive ophthalmology departments in Shanghai, managing the full spectrum of eye diseases with outstanding outcomes.

Dr. Zou has pioneered several landmark innovations in ophthalmology in China:

  • National Diabetic Retinopathy Screening Pioneer: Led the development and implementation of China's largest population-based diabetic retinopathy screening programs, using a combination of non-mydriatic fundus photography, telemedicine, and AI-assisted grading to screen millions of diabetic patients for sight-threatening retinopathy. His work has been instrumental in shaping national policy for diabetic eye disease prevention in China
  • AI-Assisted Screening: Pioneered the integration of artificial intelligence (deep learning) into diabetic retinopathy screening workflows, dramatically increasing screening efficiency and accuracy at scale
  • Anti-VEGF Therapy Leadership: One of China's leading practitioners of intravitreal anti-VEGF therapy for diabetic macular edema, wet AMD, and retinal vein occlusion, with extensive experience in treat-and-extend and pro re nata (PRN) protocols
  • Vitreoretinal Surgery Excellence: Comprehensive vitreoretinal surgery program covering complex diabetic vitrectomy, retinal detachment repair, macular hole surgery, and epiretinal membrane peeling
  • Multidisciplinary Diabetic Care: Built strong collaborative relationships with endocrinology, nephrology, and cardiology to provide integrated care for diabetic patients with systemic and ocular complications
  • Guideline Development: Contributed to the development of national clinical guidelines for diabetic retinopathy screening and management in China

Research & Academic Contributions

Dr. Zou is a prolific researcher with over 200 peer-reviewed publications in leading Chinese and international ophthalmology journals. His research focuses on:

  • Diabetic retinopathy epidemiology, screening, and prevention
  • AI and telemedicine for eye disease screening
  • Anti-VEGF therapy for diabetic macular edema and wet AMD
  • Glaucoma epidemiology and management
  • Vitreoretinal surgery outcomes
  • Population-based eye disease burden in China
  • Health economics of diabetic eye disease screening

He has been the principal investigator on multiple National Key R&D Programs and National Natural Science Foundation grants. Dr. Zou regularly presents at major international conferences including the American Academy of Ophthalmology (AAO) Annual Meeting, the Asia-Pacific Academy of Ophthalmology (APAO) Congress, and the European Society of Retina Specialists (EURETINA) Annual Meeting.

His contributions to diabetic retinopathy screening and public health ophthalmology have been recognized with numerous national and international awards, and he is frequently invited to lecture at conferences worldwide on AI-assisted screening and diabetic eye disease management.

Training & Education

As a professor at Shanghai Jiao Tong University School of Medicine and Chairman of the Diabetic Eye Disease Committee of the Chinese Medical Association Ophthalmology Branch, Dr. Zou is deeply committed to advancing ophthalmic education and training. He supervises doctoral and master's degree students and directs one of Shanghai's premier ophthalmology fellowship programs at Shanghai General Hospital.

His trainees receive comprehensive training in retinal diseases, glaucoma, cataract surgery, and diabetic eye disease management, and many now lead ophthalmology departments at major hospitals throughout China.

Hospital Affiliation

Shanghai General Hospital (Shanghai First People's Hospital)
Affiliated with Shanghai Jiao Tong University School of Medicine
100 Haining Road, Hongkou District, Shanghai 200080

Shanghai General Hospital's Department of Ophthalmology is one of the largest and most comprehensive in Shanghai, featuring:

  • Dedicated retinal disease clinic with intravitreal injection suite
  • Advanced vitreoretinal surgery operating rooms with wide-angle viewing systems
  • Comprehensive glaucoma clinic with visual field testing, OCT, and gonioscopy
  • State-of-the-art cataract surgery suite with premium IOL options
  • Refractive surgery center (LASIK, SMILE, ICL)
  • Advanced diagnostic imaging (OCT, OCT-A, fluorescein angiography, fundus photography, visual field, corneal topography)
  • Diabetic retinopathy screening program with AI-assisted grading
  • Oculoplastic and orbital surgery suite
  • Low vision rehabilitation clinic
  • International patient services with English-speaking coordinators

Patient Care Philosophy

  • Patient-Centered Care: Every treatment plan is individualized based on diagnosis, disease severity, systemic health, and patient goals
  • Prevention First: Committed to early detection and prevention of vision loss through screening, patient education, and timely intervention
  • Evidence-Based Practice: Treatment decisions guided by the latest international guidelines (AAO, EURETINA, Asia-Pacific guidelines) and Dr. Zou's own research
  • Multidisciplinary Collaboration: Close collaboration with endocrinology, nephrology, and cardiology for comprehensive diabetic patient care
  • Technology Integration: Uses the latest diagnostic and therapeutic technologies including OCT-A, anti-VEGF therapy, and AI-assisted screening
  • Transparent Communication: Clear, honest communication about diagnosis, prognosis, treatment options, and realistic expectations for vision outcomes
  • Long-term Partnership: Committed to long-term monitoring and support for patients with chronic eye diseases such as diabetic retinopathy, AMD, and glaucoma

Why Choose Dr. Zou Haidong?

  • China's Diabetic Eye Disease Authority: National leader in diabetic retinopathy screening, management, and public health policy — Chairman of the Diabetic Eye Disease Committee of the Chinese Medical Association
  • AI-Assisted Screening Pioneer: Pioneered AI-based diabetic retinopathy screening in China, bringing cutting-edge technology to population-level eye care
  • Comprehensive Retinal Expertise: Expert in anti-VEGF therapy for DME, wet AMD, and retinal vein occlusion, as well as complex vitreoretinal surgery
  • Glaucoma Mastery: Full spectrum of glaucoma management from medical therapy to advanced surgical options including MIGS
  • Premium Cataract Surgery: Expert in complex cataract surgery with premium multifocal, EDOF, and toric IOL implantation
  • Multidisciplinary Diabetic Care: Integrated approach to diabetic eye disease within a comprehensive academic medical center
  • Cost-Effective Excellence: Ophthalmic care costs in Shanghai are typically 60-75% lower than in the US or Europe
  • International Patient Experience: Experienced in coordinating care for patients from overseas

Conditions Treated

Retinal Conditions

  • Diabetic retinopathy (non-proliferative and proliferative)
  • Diabetic macular edema (DME)
  • Age-related macular degeneration (wet and dry AMD)
  • Retinal vein occlusion (branch and central)
  • Retinal artery occlusion
  • Rhegmatogenous retinal detachment
  • Tractional retinal detachment
  • Macular hole
  • Epiretinal membrane (macular pucker)
  • Myopic macular degeneration
  • Central serous chorioretinopathy
  • Inherited retinal dystrophies (Stargardt, retinitis pigmentosa)

Glaucoma

  • Primary open-angle glaucoma
  • Primary angle-closure glaucoma
  • Normal tension glaucoma
  • Secondary glaucoma (neovascular, uveitic, pseudoexfoliative)
  • Pediatric glaucoma
  • Ocular hypertension

Anterior Segment & Lens

  • Cataract (all types including complex)
  • Myopia, hyperopia, and astigmatism (refractive surgery)
  • High myopia and myopic complications
  • Corneal diseases (referral and co-management)

Oculoplastic & Orbital Conditions

  • Ptosis (eyelid drooping)
  • Entropion and ectropion
  • Lacrimal system obstruction
  • Orbital tumors
  • Thyroid eye disease (Graves' orbitopathy)

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking ophthalmic care with Dr. Zou Haidong at Shanghai General Hospital.

Pre-Treatment Support

  • Medical Record Review: Our team works with Shanghai General Hospital to review your OCT scans, fundus photographs, visual field tests, and clinical history to assess diagnosis and treatment options
  • Virtual Consultation: Arrange a video consultation with Dr. Zou's team to discuss your eye condition and treatment plan
  • Pre-treatment Assessment: Coordination of comprehensive ophthalmic evaluation including OCT, OCT-A, fluorescein angiography, visual field, and other tests as needed
  • Second Opinion: Expert second opinion on diagnosis and optimal treatment strategy (anti-VEGF vs. laser vs. surgery)
  • Cost Transparency: Detailed cost estimate including evaluation, injections or surgery, and follow-up
  • Visa Assistance: Guidance on obtaining medical visa and invitation letters
  • Accommodation: Help finding suitable housing near Shanghai General Hospital for patient and family

During Treatment

  • Professional Medical Interpretation: Experienced interpreters for all medical interactions
  • Hospital Admission Support: Assistance with registration, payment, and navigation
  • Family Support: Accommodation and support for accompanying family members
  • Procedure Coordination: Support during intravitreal injections, laser treatments, or surgical procedures
  • Post-procedure Care: Comprehensive support during recovery including eye drop management and activity restrictions
  • 24/7 Emergency Support: Round-the-clock assistance throughout your stay

Post-Treatment Care

  • Discharge Planning: Coordination of post-discharge care and monitoring schedule
  • Medical Report Translation: Complete translation of examination reports, OCT results, and discharge summaries
  • Follow-up Coordination: Arrange post-treatment clinic visits and imaging surveillance
  • Long-term Monitoring Plan: Clear guidance on ongoing surveillance schedule for chronic conditions (diabetic retinopathy, AMD, glaucoma)
  • Telemedicine Follow-up: Virtual consultations for ongoing monitoring after returning home
  • Coordination with Home Ophthalmologists: Communication with your local ophthalmologist or retinal specialist for ongoing management
  • Lifelong Support: Ongoing assistance for chronic eye conditions requiring long-term monitoring

Schedule Your Consultation

If you or a loved one is experiencing vision problems from diabetic retinopathy, macular degeneration, glaucoma, cataracts, or another eye condition, Dr. Zou Haidong at Shanghai General Hospital offers world-class ophthalmic expertise at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to:

  • Request a medical record and imaging review to assess your eye condition and treatment options
  • Schedule a virtual consultation with Dr. Zou's ophthalmology team
  • Receive a detailed treatment plan and cost estimate
  • Start your journey toward preserving and restoring your vision in Shanghai

Bridging international patients with China's finest ophthalmologists — because protecting your vision means protecting your world.

0 Kommentare

Hinterlasse einen Kommentar